35 results on '"Zou, Yaohong"'
Search Results
2. Low dosage use of cyclophosphamide improves the survival of patients with systemic lupus erythematosus
3. Clinical and laboratorial outcome of different age-onset systemic lupus erythematosus patients in Jiangsu, China: a multicentre retrospective study
4. Creatinine clearance rate predicts prognosis of patients with systemic lupus erythematosus: a large retrospective cohort study
5. The relationship of polluted air and drinking water sources with the prevalence of systemic lupus erythematosus: a provincial population-based study
6. Analysis of predictive factors for treatment resistance and disease relapse in Takayasu’s arteritis
7. Smoking quantity determines disease activity and function in Chinese patients with ankylosing spondylitis
8. Comparison of Contributors to Mortality Differences in SLE Patients with Different Initial Disease Activity: A Larger Multicenter Cohort Study
9. Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu’s arteritis
10. Clinical patterns and characteristics of ankylosing spondylitis in China
11. Thalidomide treatment in cutaneous lesions of systemic lupus erythematosus: a multicenter study in China
12. Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus
13. Determination of Anticyclic Citrullinated Peptide Based on Biotin–Streptavidin-Amplified Time-Resolved Fluoroimmunoassay
14. Low Dosage and Long-Term Use of Cyclophosphamide Improve the Survival of Patients with Systemic Lupus Erythematosus
15. FIB-4 index associated with mortality risk of patients with systemic lupus erythematosus: a large retrospective cohort study
16. Creatinine clearance rate predicts prognosis of patients with systemic lupus erythematosus: a large retrospective cohort study
17. Association of antimalarial drugs with decreased overall and cause specific mortality in systemic lupus erythematosus
18. Efficacy and safety of leflunomide treatment in Takayasu arteritis: Case series from the East China cohort
19. Mortality of hospitalized systemic lupus erythematosus patients in China: 0782
20. Clinical manifestation and prognosis of re-hospitalized systemic lupus erythematosus patients in China: 0745
21. A rare variant of RNF123 in familial ankylosing spondylitis causes dysfunction of osteoclast formation
22. Association of antimalarial drugs with decreased overall and cause specific mortality in systemic lupus erythematosus.
23. A rare variant of RNF123 in familial ankylosing spondylitis causes dysfunction of osteoclast formation.
24. Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus
25. Genetic predictors of efficacy and toxicity of iguratimod in patients with rheumatoid arthritis
26. Evaluation of Left Atrial Function by Real-time 3-D Echocardiography in Patients with Systemic Lupus Erythematosus
27. Determination of Anticyclic Citrullinated Peptide Based on Biotin-Streptavidin-Amplified Time-Resolved Fluoroimmunoassay
28. Prognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort.
29. Detection of Anti-Cyclic Citrullinated Peptide Using a Time-Resolved Fluoroimmunoassay
30. A HYPERSENSITIVE BIOTIN-AVIDIN-TRFIA FOR QUANTITATIVE DETECTION OF ANA-Ig(GAM) AND ITS CLINICAL APPLICATION
31. Prognostic Indicators of Hospitalized Patients with Systemic Lupus Erythematosus: A Large Retrospective Multicenter Study in China
32. Evaluation of Left Atrial Function by Real-time 3-D Echocardiography in Patients with Systemic Lupus Erythematosus
33. Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus.
34. [Clinical features and prognosis of patients with lupus nephritis].
35. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.